Cargando...

Current Status of Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin's Lymphoma

Despite the relatively high long-term disease-free survival (DFS) rate for patients with Hodgkin lymphoma (HL) with modern combination chemotherapy or combined modality regimens, ∼20% of patients die from progressive or relapsed disease. The standard treatment for relapsed and primary refractory HL...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Colpo, Anna, Hochberg, Ephraim, Chen, Yi-Bin
Formato: Artigo
Idioma:Inglês
Publicado: AlphaMed Press 2012
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3267827/
https://ncbi.nlm.nih.gov/pubmed/22210089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0177
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!